BEN vs NRIX · P/E 36, rev $8.77B vs rev $54.5M
Franklin Resources Inc (BEN) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the BEN and NRIX stock pages for the full models.
Not investment advice.